Northrop Grumman Corp. buy BNP Paribas Exane
Start price
18.11.25
/
50%
€494.00
Target price
18.11.26
€612.52
Performance (%)
-2.33%
Price
28.07.26
€482.50
Summary
This prediction is currently active. With a performance of -2.33%, the BUY prediction by BNP_Paribas_Exane is trending in the wrong direction. This prediction currently runs until 18.11.26. The prediction end date can be changed by BNP_Paribas_Exane at any time. BNP_Paribas_Exane has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Northrop Grumman Corp. | 7.653% | 7.653% |
| iShares Core DAX® | 1.717% | 3.368% |
| iShares Nasdaq 100 | -4.565% | -4.238% |
| iShares Nikkei 225® | -7.120% | -11.869% |
| iShares S&P 500 | -0.894% | 1.687% |
Comments by BNP_Paribas_Exane for this prediction
In the thread Northrop Grumman Corp. diskutieren
Northrop Grumman (NYSE:NOC) is now covered by analysts at BNP Paribas Exane. They set an "outperform" rating and a $710.00 price target on the stock.
Ratings data for NOC provided by MarketBeat

